These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21921455)

  • 1. [Acute stroke management in Japan].
    Iguchi Y; Kimura K
    Rinsho Shinkeigaku; 2010 Nov; 50(11):826. PubMed ID: 21921455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
    Minematsu K
    No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
    [No Abstract]   [Full Text] [Related]  

  • 3. Large numbers of stroke physicians should be used to treat large numbers of stroke patients with IV rt-PA.
    Iguchi Y; Kimura K; Shibazaki K
    J Neurol Sci; 2011 Mar; 302(1-2):81-4. PubMed ID: 21195435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subjects in the acute thrombolytic therapy by intravenous administration of rt-PA].
    Suzuki A; Moroi J; Nakase T; Yoshioka S; Nagata K; Sato Y; Maeda T; Sawada M; Kobayashi N; Ogura N; Izumi M
    No To Shinkei; 2006 Nov; 58(11):931-6. PubMed ID: 17133998
    [No Abstract]   [Full Text] [Related]  

  • 5. [The future perspective of acute thrombolytic therapy for acute ischemic stroke].
    Matsuki T; Toyoda K
    Nihon Rinsho; 2016 Apr; 74(4):613-20. PubMed ID: 27333749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for acute stroke in patients with cancer.
    Casado-Naranjo I; Calle ML; Falcón A; Serrano A; Portilla JC; Ramírez-Moreno JM
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1404-5. PubMed ID: 21084264
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.
    Iguchi Y; Kimura K; Shibazaki K; Iwanaga T
    J Neurol Sci; 2009 Apr; 279(1-2):66-9. PubMed ID: 19185882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.
    Weimar C; Kraywinkel K; Maschke M; Diener HC;
    Cerebrovasc Dis; 2006; 22(5-6):429-31. PubMed ID: 16912477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New era has begun since the approval of thrombolytic therapy for acute ischemic stroke in Japan].
    Minematsu K
    Rinsho Shinkeigaku; 2008 Nov; 48(11):889-91. PubMed ID: 19198107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.
    Katzan IL; Sila CA; Furlan AJ
    Stroke; 2001 Apr; 32(4):861-5. PubMed ID: 11283383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential combination of two intravenous thrombolytics (recombinant tissue plasminogen activator/tenecteplase) in a patient with stroke and cardioembolic basilar artery occlusion.
    Smadja D; Olindo S; Saint-Vil M; Chausson N
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):68-71. PubMed ID: 19110148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining intravenous recombinant tissue plasminogen activator failure.
    Guerrero WR; Grotta JC
    Stroke; 2013 Mar; 44(3):819-21. PubMed ID: 23339963
    [No Abstract]   [Full Text] [Related]  

  • 14. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
    Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Neuroimaging; 2011 Apr; 21(2):113-20. PubMed ID: 19909396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of stroke physicians is the key to preparing IV rt-PA.
    Iguchi Y; Kimura K; Shibazaki K; Aoki J
    Cerebrovasc Dis; 2009; 28(5):460-7. PubMed ID: 19738375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
    Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telestroke-guided intravenous tissue-type plasminogen activator treatment achieves a similar clinical outcome as thrombolysis at a comprehensive stroke center.
    Zaidi SF; Jumma MA; Urra XN; Hammer M; Massaro L; Reddy V; Jovin T; Lin R; Wechsler LR
    Stroke; 2011 Nov; 42(11):3291-3. PubMed ID: 21885843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.